Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
- DOI
- 10.3389/fimmu.2019.00725
- Published
- 2019-04-09
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2019.00725,
title = {Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial},
author = {Mansi Saxena and Rachel L. Sabado and Melissa La Mar and Hiroshi Mohri and Andres M. Salazar and Hanqing Dong and Joel Correa Da Rosa and Martin Markowitz and Nina Bhardwaj and Elizabeth Miller},
year = {2019},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2019.00725},
url = {https://doi.org/10.3389/fimmu.2019.00725}
}RIS
TY - JOUR TI - Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial AU - Mansi Saxena AU - Rachel L. Sabado AU - Melissa La Mar AU - Hiroshi Mohri AU - Andres M. Salazar AU - Hanqing Dong AU - Joel Correa Da Rosa AU - Martin Markowitz AU - Nina Bhardwaj AU - Elizabeth Miller PY - 2019 JO - Frontiers in Immunology DO - 10.3389/fimmu.2019.00725 UR - https://doi.org/10.3389/fimmu.2019.00725 ER -
APA
Saxena, M., Sabado, R. L., Mar, M. L., Mohri, H., Salazar, A. M., Dong, H., Rosa, J. C. D., Markowitz, M., Bhardwaj, N., & Miller, E. (2019). Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2019.00725
Source records
- crossref · retrieved 2026-09-27T13:34:57.356Z